Clinical Trial NCT05795140

Trial

Novartis – CLNP023F12001B (NCT05795140)

Clinical trial ID

NCT05795140

Drug name

LNP023

Company:

Novartis Pharmaceuticals

Drug trade name

Iptacopan

Clinicaltrials.gov

Learn more

Phase of study

3

Current status

Recruiting

Start

05/2024

Substance

Research question

to evaluate the long-term safety, tolerability, and efficacy of iptacopan in participants with aHUS.

Delivery method of drug

Frequency

Clinical trial locations

Brazil, China, Czechia, India,